2022 annual financial data
Xenon Pharmaceuticals 2022 Operating margin
Xenon Pharmaceuticals 2022 operating margin with verified reported values.
Direct answer
Operating margin was -1,368.91%.
Operating income was -129,143,000 USD and net income was -125,373,000 USD.
Operating cash flow was -98,430,000 USD.
Get free Xenon Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,434,000 USD
- Operating income
- -129,143,000 USD
- Net income
- -125,373,000 USD
- Operating cash flow
- -98,430,000 USD